MAPK3 and cardiac hypertrophy: Cao et al. (2020) have also reported that excessive ERK1/2 activation induced cardiac hypertrophy. A previous study has reported that almost all MAPKs are activated in pathological cardiac hypertrophy (Toischer et al., 2010), and this phenomenon was confirmed in this study.